Novo Nordisk(NVO) - 2025 Q4 - Earnings Call Transcript

Novo Nordisk (NYSE:NVO) Q4 2025 Earnings call February 05, 2026 08:15 AM ET Speaker1Good afternoon, everyone. I'm James Quigley, European Pharma Analyst here at Goldman Sachs, and it's a pleasure to welcome you to this fourth-quarter results presentation for Novo Nordisk. We've got the pleasure to be joined by Mike Doustdar, CEO; Karsten Munk Knudsen, CFO; and Martin Holst Lange, the Chief Scientific Officer. So with that, Mike, thanks for joining us. Over to you.Speaker5Thank you very much for hosting us. ...